Word: growth
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Bill Gross oversee the world's biggest bond fund, his views often sway markets. In a late December interview with TIME's John Curran, Gross pointed to the second half of 2010 as a period when investors large and small will reckon with a new reality of poor economic growth and a Federal Reserve that is hard-pressed to offer much help...
...first half will be dominated by government stimulus and by inventory accumulation or a lack of [inventory] liquidation among businesses. I expect nothing from consumer [spending] and nothing really from housing or really any of the standard cyclical leading sectors. It's hard to put a number on GDP growth rates, but let's say 4% in the first half and then 2% in the second half, which would basically call for some additional help. (See TIME's 2009 Person of the Year: Federal Reserve Chairman Ben Bernanke...
Given all the crosscurrents, what will the investor's world look like in the years ahead? In a new-normal world, growth will be half of what it was, profit growth will be half of what it was, and returns on almost all assets - including bonds - will be half of what we've grown used to. Further, the U.S. economy and other [developed] economies have provided as a whole 7% to 9% returns over the past 10, 20 years, and investors got used to that. That's one of the reasons why states and pension funds with the long-term...
...talk about health care reform. Do you think the Democrats have gotten it basically right or wrong when it comes to slowing the growth of medical spending? The core point at which health care costs explode is the point at which the doctor and the patient sit down together to make a decision about what they should do for care. We have not concentrated enough, in our thinking about reform, on that moment. What we want is care that is much better organized. We are going to need approaches like checklists to get rid of wasted care and to make...
...devils will eventually need a vaccine, and there is hope that this research may help scientists develop one. The team compiled a catalog of devil genes that affect the tumor and may contribute to its growth; these could be useful targets for designing a future vaccine. The difficulty will be creating a treatment that attacks the tumor, but spares healthy cells. "The key in a vaccine is not to create immune action that would hurt the devils by attacking their Schwann cells," says Papenfuss. "Now we can look for specific markers on the tumor cells to attack." Tough as they...